[HTML][HTML] Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis

…, J Massey, IN Bruce, J Bluett, M Feletar… - Nature …, 2015 - nature.com
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis and,
despite the larger estimated heritability for PsA, the majority of genetic susceptibility loci …

[HTML][HTML] Effects of Hylan GF 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single …

…, AE Wluka, G Grant, P Marks, M Feletar… - BMC musculoskeletal …, 2011 - Springer
Background Although viscosupplementation is an effective symptomatic treatment for knee
osteoarthritis (OA), the effect of longer term administration on articular cartilage has not been …

Prolonged remission in systemic lupus erythematosus.

MB Urowitz, M Feletar, IN Bruce, D Ibañez… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To determine the frequency of prolonged remission in systemic lupus
erythematosus (SLE) using strict criteria for remission and to define disease characteristics and …

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis

…, H Marzo-Ortega, PS Helliwell, M Feletar… - Annals of the …, 2017 - ard.bmj.com
Objectives Psoriatic arthritis (PsA) is a chronic inflammatory arthritis, with a strong heritable
component, affecting patients with psoriasis. Here we attempt to identify genetic variants …

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus

…, A Budu-Aggrey, S Uebe, IN Bruce, M Feletar… - Annals of the …, 2015 - ard.bmj.com
Objectives Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis;
it has a higher estimated genetic component than psoriasis alone, however most genetic …

Choosing the right treatment for patients with psoriatic arthritis

M Noviani, M Feletar, P Nash… - Therapeutic advances …, 2020 - journals.sagepub.com
Psoriatic arthritis (PsA) is a chronic inflammatory condition with articular and extra-articular
manifestations: peripheral arthritis, axial disease, enthesitis, dactylitis, psoriasis, inflammatory …

The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada.

DD Gladman, RJ Cook, C Schentag, M Feletar… - The Journal of …, 2004 - jrheum.org
OBJECTIVES: To evaluate whether rheumatologists experienced in psoriatic arthritis (PsA)
assess peripheral and axial involvement in the same way and to consider core clinical …

Management of dactylitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations

…, I Steinkoenig, J Chau, M Feletar, M Vis… - The Journal of …, 2023 - jrheum.org
Objective This literature review aimed to identify the most efficacious current interventions
for dactylitis and provide up-to-date scientific evidence to support the 2021 Group for …

Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia

…, M Turner, M Mundae, M Micallef, M Feletar… - JAMA Network …, 2023 - jamanetwork.com
Importance There is a need for observational studies to supplement evidence from clinical
trials, and the target trial emulation (TTE) framework can help avoid biases that can be …

Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients

M Feletar, JE Brockbank, CT Schentag… - Annals of the …, 2004 - ard.bmj.com
Objective: To evaluate the effectiveness and toxicity of infliximab in patients with recalcitrant
psoriatic arthritis (PsA). Methods: Patients with treatment resistant PsA and at least six …